Form 4 for TNXP Tonix Pharmaceuticals Holding Corp.
Accepted 2026-08-31 08:00:21 ET · period of report 2026-08-27 · accession 0001493152-26-040736 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-31 08:00 | 2026-08-27 | TNXP | LEDERMAN SETH | CEO, Dir | P - Purchase | $13.79 | +2,000 | 11.0K | +22% | +$27.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.001 par value | 2026-08-27 | P | A | 2,000 | $13.79 | 11,005 | I By IRA Account | — | — | (F1) Reporting person may be deemed a control person of this entity. |